Is
the era of code stacking about to end? The clock is certainly
ticking for molecular diagnostic tests. Effective March 1, 2012,
one of Medicare's larger carriers is proposing new processes that
will affect claims for molecular diagnostic tests (MDT) and laboratory-developed
tests (LDT).
This
milestone development has the potential to affect every laboratory
that uses code stacks when submitting claims for MDTs and LDTs.
In recent weeks, Palmetto GBA has published two proposed local-coverage
determinations (LCD) that would change how code stacks are used
for MDTs and LDTs, starting in the J1 region.
Palmetto
GBA also released details about a proposed new "Molecular
Diagnostics Services Program" or MolDx for short. MolDx will
also launch on March 1, 2012, and to comply, labs would need to
register every MDT and LDT, then submit clinical and scientific
material for each test. This information would be evaluated by
a special review panel, after which Palmetto GBA would make a
coverage determination for each test.
By special arrangement, this audio conference was held on
Tuesday, December 20, 2011 will feature Palmetto's Medical
Director, Elaine Jeter, M.D. and Vice President, Mike Barlow.
You and your lab team can get first-hand information about why
these proposals were put forth, along with specific details about
how Palmetto GBA plans to implement the two proposed LCDs and
MolDx.
For
pathology groups and clinical labs moving forward with molecular
diagnostics testing, this is a "must-attend" event.
You'll get the knowledge you need to ensure that your lab's MDT
and LDT claims comply with the proposed changes. Not only will
you hear directly from the Palmetto GBA executives tasked with
addressing the issues triggered by the growing number of code-stacked
claims, you'll also get answers to your specific questions when
we open up the phone lines to Q&A from the audience.
This
high-value, low-cost 90-minute audio conference will help you
and your entire staff develop a strategic plan to respond to the
proposed new processes involving molecular diagnostic tests and
LDTs. It's information you can't get from any other source, so
be sure you register today to guarantee your place at this important
event!
THE
DARK REPORT AUDIO CONFERENCE AT A GLANCE
COST: $245 per digital recording series
TO ORDER LIVE AUDIO RECORDINGS NOW:Click
here or call 1-800-560-6363 toll-free
For
one low price—just $195 (through 12/9/11; $245 thereafter)—you
and your entire team can take part in this fast-paced, insightful
audio conference. Best of all, you'll be able to connect personally
with our speakers when we open up the phone lines for live Q&A.
Here's just some of what you’ll learn during this in-depth
90-minute conference:
Why
do code stacked claims cause problems for health insurers?
How do the two proposed local coverage determinations (LCD)
address code-stacking issues?
Can my lab expect to be paid if it submits code-stacked molecular
test claims after March 1, 2012?
What is the purpose of the molecular test registry?
How will the clinical and scientific material in support of
my lab’s tests be evaluated?
Why do I need a “Z-Code” for each of my lab’s
molecular diagnostic tests and LDTs?
Will there be flexibility in the timelines?
…and
much more!
How
to Order Live Audio:
1. Online
2. Call toll free: 800-560-6363.
Your
audio conference order includes:
Downloadable
PowerPoint presentations from our speakers
A
full transcript emailed to you soon after the conference
Order
Now!Or for more
information, call us toll-free at 800-560-6363.
Distinguished
Presenters:
Mike
Barlow is Vice President of Jurisdiction 1
A/B MAC Operations at Palmetto GBA, LLC where he leads
large-scale Medicare operations in offices in South
Carolina, Ohio and Georgia. Mr. Barlow has oversight
responsibility for activities that involve provider
enrollment analysts, nurse reviewers (RNs), claims processors,
customer service representatives, document control technicians,
ombudsmen/provider education consultants, business analysts,
project specialists and other support personnel. Mr.
Barlow graduated with a bachelor of science degree from
the University of Southern Mississippi.
Elaine
K. Jeter, M.D. is the Palmetto GBA J11 Medical
Director. She received a bachelor of science degree
from the State University of New York at Genesee in
biology/marine science and an MS in biology from the
University of South Carolina. Dr. Jeter received her
MD from Medical University of South Carolina (MUSC),
and completed a five-year residency in anatomical and
clinical pathology. She has AP/CP boards from the American
College of Pathology, and specialty boards in blood-banking/transfusion
medicine. Dr. Jeter was on the faculty at MUSC in pathology
and in the private practice of pathology for many years
prior to joining Palmetto GBA.
Robert L. Michel (Moderator),
is Editor-In-Chief of THE DARK REPORT and DarkDaily.com. Both
are respected sources of business intelligence for laboratory
CEOs and pathologists. He is considered one of the profession’s
leading commentators on issues involving clinical laboratory
management and operations, as well as strategic trends in the
lab testing industry.
ACCENT®
Continuing Education Credit
The American Association of Clinical Chemistry (AACC) designates
this program for a maximum of 1.5 ACCENT® credit hours towards
the AACC Clinical Chemist’s Recognition Award. AACC is an
approved provider of continuing education for clinical laboratory
scientists in the states of California, Florida, Louisiana, Montana,
Nevada, North Dakota, Rhode Island, and West Virginia.
